Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-25T03:03:41.027Z Has data issue: false hasContentIssue false
  • English
  • Français

Cytokine production by blood mononuclear cells from in-patients with anorexia nervosa

Published online by Cambridge University Press:  09 March 2007

Esther Nova ,
Sonia Gómez-Martínez ,
Gonzalo Morandé  and
Ascensión Marcos
Esther Nova
Affiliation:
Instituto de Nutrición y Bromatología (CSIC-UCM), Facultad de Farmacia, Universidad Complutense, Ciudad Universitaria, 28040 Madrid, Spain
Sonia Gómez-Martínez
Affiliation:
Instituto de Nutrición y Bromatología (CSIC-UCM), Facultad de Farmacia, Universidad Complutense, Ciudad Universitaria, 28040 Madrid, Spain
Gonzalo Morandé
Affiliation:
Hospital Niño Jesús. C/Menéndez Pelayo 65, 28009 Madrid, Spain
Ascensión Marcos*
Affiliation:
Instituto de Nutrición y Bromatología (CSIC-UCM), Facultad de Farmacia, Universidad Complutense, Ciudad Universitaria, 28040 Madrid, Spain
*
*Corresponding author:Dr Ascensión Marcos, fax +34 91 549 5079, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Although protein–energy malnutrition is a common cause of immunodeficiency, the immune function in underweight anorexia nervosa (AN) patients usually seems to be better preserved than would be expected. However, a deranged cytokine production and its consequences are currently being investigated in these patients. This study was aimed at measuring, over time, the capacity of peripheral blood mononuclear cells (PBMC) from AN in-patients to produce several cytokines involved in the regulation of immune responses. The in vitro production of interferon (IFN)-γ, interleukin (IL)-2, tumour necrosis factor (TNF)-α, IL-6 and IL-1β by phytohaemagglutinin-stimulated PBMC were assessed on forty female adolescents with AN. These measures were carried out twice, upon hospital admission and at discharge, which occurred on average after 1 month. Thirty-five control subjects were also studied. Cytokines were measured by ELISA kits. The production of TNF-α and IL-6 was lower and production of IL-1β higher in AN patients than in the control group at both time points of assessment. Refeeding for 1 month was not enough time to reverse these differences and patients still had a low body weight at discharge. IFN-γ production was lower in the patients than in control subjects only at discharge and no differences were found in IL-2 production between both groups. The results suggest that a mechanism involving modifications in the secretion pattern of proinflammatory cytokines could explain some immune function findings in underweight AN patients.

Keywords

Cytokine productionMalnutritionAnorexia nervosaPhytohaemagglutinin-stimulated peripheral blood mo
Type
Research Article
Information
British Journal of Nutrition , Volume 88 , Issue 2 , August 2002 , pp. 183 - 188
Copyright
Copyright © The Nutrition Society 2002

References

Allende, LM, Corell, A, Manzanares, J, Madruga, D, Marcos, A, Madrono, A, Lopez-Goyanes, A, Garcia-Perez, MA, Moreno, JM, Rodrigo, M, Sanz, F & Arnaiz-Villena, A (1998) Immunodeficiency associated with anorexia nervosa is secondary and improves after refeeding. Immunology 94, 543–551.CrossRefGoogle ScholarPubMed
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Washington, DC: APA.Google Scholar
Armstrong-Esther, CA, Lacey, JH, Crisp, AH & Bryant, TN (1978) An investigation of the immune response of patients suffering from anorexia nervosa. Postgraduate Medical Journal 54, 395–399.CrossRefGoogle ScholarPubMed
Bessler, H, Karp, L, Notti, I, Apter, A, Tyano, S, Djaldetti, M & Weizman, R (1993) Cytokine production in anorexia nervosa. Clinical Neuropharmacology 16, 237–243.CrossRefGoogle ScholarPubMed
Blalock, JE, Harbour-McMenamin, D & Smith, EM (1985) Peptide hormones shared by the neuroendocrine and immunologic systems. Journal of Immunology 135, 858s–861s.Google ScholarPubMed
Bowen, DL, Lane, HC & Fauci, AS (1985) Immunopathogenesis of the acquired immunodeficiency syndrome. Annals of Internal Medicine 103, 704–709.CrossRefGoogle ScholarPubMed
Cason, J, Ainley, CC, Volstencroft, RA, Norton, KRW & Thompson, RPH (1986) Cell mediated immunity in anorexia nervosa. Clinical and Experimental Immunology 64, 370–375.Google ScholarPubMed
Chandra, RK & Kumari, S (1994) Effects of nutrition on the immune system. Nutrition 10, 207–210.Google ScholarPubMed
Day, HE & Akil, H (1996) Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1 beta: implications for mechanism of action. Neuroendocrinology 63, 207–218.CrossRefGoogle ScholarPubMed
Fruscella, P, Sottocorno, M, Di Braccio, M, Diomede, L, Piccardi, N, Cagnotto, A, Grossi, G, Romano, M, Mennini, T & Roma, G (2001) 1,5-Benzodiazepine tricyclic derivatives exerting anti-inflammatory effects in mice by inhibiting interleukin-6 and prostaglandin E(2)production. Pharmacology Research 43, 445–452.CrossRefGoogle Scholar
Golla, AG, Larson, LA, Anderson, CF, Lucas, AR, Wilson, WR & Tomasi, TB (1981) Immunological assessment of patients with anorexia nervosa. American Journal of Clinical Nutrition 34, 2756–2762.CrossRefGoogle ScholarPubMed
Hernandez, M, Castellet, J, Narvaíza, JL, Rincón, JM, Ruiz, E, Sánchez, E, Sobradillo, B & Zuzimendi, A (1988) Curvas y Tablas de Crecimiento (Growth Charts and Tables) [Faustino Orbegozo Foundation, editors]. Madrid: Carsi.Google Scholar
Holden, RJ & Pakula, IS (1996) The role of tumour necrosis factor-α in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Medical Hypothesis 47, 423–438.CrossRefGoogle ScholarPubMed
Llewellyn-Jones, D & Abraham, SF (1984) Quetelet index in the diagnosis of anorexia nervosa. British Medical Journal 288, 1800.CrossRefGoogle ScholarPubMed
Magilavy, DB & Rothstein, JL (1988) Spontaneous production of tumor necrosis factor α by Kupffer cells of MRL/lpr mice. Journal of Experimental Medicine 168, 789–794.CrossRefGoogle ScholarPubMed
Marcos, A (1997) The immune system in eating disorders: An overview. Nutrition 13, 853–862.CrossRefGoogle ScholarPubMed
Marcos, A, Varela, P, Santacruz, I, Muñoz-Velez, A & Morande, G (1993) Nutritional status and immunocompetence in eating disorders. A comparative study. European Journal of Clinical Nutrition 47, 787–793.Google ScholarPubMed
Nagata, T, Tobitani, W, Kiriike, N, Iketani, T & Yamagami, S (1999) Capacity to produce cytokines during weight restoration in patients with anorexia nervosa. Psychosomatic Medicine 61, 371–377.CrossRefGoogle ScholarPubMed
Nawrocka, W, Sztuba, B & Zimecki, M (2001) Synthesis and immunotropic properties of 5-substituted 1,5-benzodiazepin-2-ones derivatives in cultures of human peripheral blood cells, Part III. Archiv der Pharmazie 334, 11–16.3.0.CO;2-Y>CrossRefGoogle Scholar
Pawlikowski, M, Lyson, K, Kunert-Radek, J & Stepien, H (1988) Effect of benzodiazepines on the proliferation of mouse spleen lymphocytes in vitro. Journal of Neural Transmission 73, 161–166.CrossRefGoogle ScholarPubMed
Pellegrino, TC & Bayer, BM (1998) Modulation of immune cell function following fluoxetine administration in rats. Pharmacology, Biochemistry and Behaviour 59, 151–157.CrossRefGoogle ScholarPubMed
Polack, E, Nahmod, VE, Emeric-Sauval, E, Bello, M, Costas, M, Finkielman, S & Arzt, E (1993) Low lymphocyte interferon-gamma production and variable proliferative response in anorexia nervosa patients. Journal of Clinical Immunology 13, 445–451.CrossRefGoogle ScholarPubMed
Pomeroy, C, Eckert, E, Hu, S, Eiken, B, Mentink, M, Crosby, RD & Chao, CC (1994) Role of interleukin-6 and transforming growth factor-β in anorexia nervosa. Biological Psychiatry 36, 836–839.CrossRefGoogle ScholarPubMed
Preble, OT, Rothko, K, Klippel, JH, Friedman, RM & Johnston, MI (1983) Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. Journal of Experimental Medicine 157, 2140–2146.CrossRefGoogle ScholarPubMed
Schattner, A, Steinbock, M, Tepper, R, Schonfeld, A, Vaisman, N & Hahn, T (1990 a) Tumour necrosis factor production and cell-mediated immunity in anorexia nervosa. Clinical and Experimental Immunology 79, 62–66.CrossRefGoogle ScholarPubMed
Schattner, A, Tepper, R, Steinbock, M, Vaisman, N, Hahn, T & Schonfeld, A (1990 b) TNF, interferon-γ, and cell-mediated cytotoxicity in anorexia nervosa; effect of refeeding. Journal of Clinical and Laboratory Immunology 32, 183–184.Google ScholarPubMed
Sullivan, PF (1995) Mortality in anorexia nervosa. American Journal of Psychiatry 152, 1073–1074.Google ScholarPubMed
Tepper, R, Weizman, A, Apter, A, Tyano, S & Beyth, Y (1992) Elevated plasma immunoreactive beta-endorphin in anorexia nervosa. Clinical Neuropharmacology 15, 387–391.CrossRefGoogle ScholarPubMed
Vaisman, N & Hahn, T (1991) Tumor necrosis factor-α and anorexia – cause or effect? Metabolism 40, 720–723.CrossRefGoogle ScholarPubMed
Vaisman, N, Barak, Y, Hahn, T, Karov, Y, Malach, L & Barak, V (1996) Defective in vitro granulopoiesis in patients with anorexia nervosa. Pediatric Research 40, 108–111.CrossRefGoogle ScholarPubMed
Varela, P, Marcos, A, Muñoz-Velez, A, Santacruz, I & Requejo, A (1988) Delayed hypersensitivity skin test in anorexia nervosa and bulimia. Medical Science Research 16, 1135.Google Scholar
Wade, S, Bleiberg, F, Mossé, A, Lubetzki, J, Flavigny, H, Chapuis, P, Roceh, D, Lemonnier, D & Dardenne, M (1985) Thymulin (Zn-Facteur Thymique Serique) activity in anorexia nervosa patients. American Journal of Clinical Nutrition 42, 275–280.CrossRefGoogle ScholarPubMed
Walsh, BT, Roose, SP, Katz, JL, Dyrenfurth, I, Wright, L, Vande Wiele, R & Glassman, AH (1987) Hypothalamic–pituitary–adrenal–cortical activity in anorexia nervosa and bulimia. Psychoneuroendocrinology 12, 131–140.CrossRefGoogle ScholarPubMed
Yaqoob, P, Newsholme, EA & Calder, PC (1999) Comparation of cytokine production in cultures of whole human blood and purified mononuclear cells. Cytokine 11, 600–605.CrossRefGoogle Scholar
Yirmiya, R, Pollak, Y, Barak, O, Avitsur, R, Ovadia, H, Bette, M, Weihe, E & Weinfeld, J (2001) Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24, 531–544.CrossRefGoogle ScholarPubMed